Thomas J. Tisch, 10% Owner at SYNAGEVA BIOPHARMA CORP (GEVA), bought 1,200,000 shares at $25.18 ($30.2M) on 2012-01-10, disclosed to the SEC on 2012-01-11.
Open-market purchase of $30.2M GEVA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| GEVA | BUY | 2012-07-13 | $1.5M | — | Filing → |
| GEVA | BUY | 2012-01-17 | $3.0M | — | Filing → |